| Valuing health‐related quality of life: An EQ‐5D‐5L value set for England NJ Devlin, KK Shah, Y Feng, B Mulhern, B Hout Health economics 27 (1), 7-22, 2018 | 1239 | 2018 |
| The influence of cost‐effectiveness and other factors on nice decisions H Dakin, N Devlin, Y Feng, N Rice, P O'neill, D Parkin Health economics 24 (10), 1256-1271, 2015 | 283 | 2015 |
| Assessing the performance of the EQ-VAS in the NHS PROMs programme Y Feng, D Parkin, NJ Devlin Quality of Life Research 23 (3), 977-989, 2014 | 268 | 2014 |
| Assessing the health of the general population in England: how do the three-and five-level versions of EQ-5D compare? Y Feng, N Devlin, M Herdman Health and quality of life outcomes 13 (1), 171, 2015 | 179 | 2015 |
| Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets B Mulhern, Y Feng, K Shah, MF Janssen, M Herdman, B van Hout, ... PharmacoEconomics, 1-15, 2018 | 100 | 2018 |
| New methods for modelling EQ‐5D‐5L value sets: An application to English data Y Feng, NJ Devlin, KK Shah, B Mulhern, B Hout Health economics 27 (1), 23-38, 2018 | 82 | 2018 |
| Quantifying the economic impact of government and charity funding of medical research on private research and development funding in the United Kingdom J Sussex, Y Feng, J Mestre-Ferrandiz, M Pistollato, M Hafner, P Burridge, ... BMC medicine 14 (1), 32, 2016 | 79 | 2016 |
| What determines the shape of an EQ-5D index distribution? D Parkin, N Devlin, Y Feng Medical Decision Making 36 (8), 941-951, 2016 | 47 | 2016 |
| An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D Y Feng, M Herdman, F van Nooten, C Cleeland, D Parkin, S Ikeda, ... Quality of Life Research 26 (8), 2067-2078, 2017 | 31 | 2017 |
| Association between market concentration of hospitals and patient health gain following hip replacement surgery Y Feng, M Pistollato, A Charlesworth, N Devlin, C Propper, J Sussex Journal of health services research & policy 20 (1), 11-17, 2015 | 30 | 2015 |
| Pay for performance for specialised care in England: Strengths and weaknesses Y Feng, SR Kristensen, P Lorgelly, R Meacock, MR Sanchez, L Siciliani, ... Health Policy, 2019 | 19 | 2019 |
| The Tougher the Better: an economic analysis of increased payment thresholds on the performance of General Practices Y Feng, A Ma, S Farrar, M Sutton Health economics 24 (3), 353-371, 2015 | 15 | 2015 |
| The value of international volunteers experience to the NHS B Zamora, M Gurupira, MR Sanchez, Y Feng, K Hernandez-Villafuerte, ... Globalization and health 15 (1), 31, 2019 | 12 | 2019 |
| Valuing EQ-5D-5L health states ‘in context’using a discrete choice experiment A Cole, K Shah, B Mulhern, Y Feng, N Devlin The European Journal of Health Economics 19 (4), 595-605, 2018 | 12 | 2018 |
| Distribution of the EQ-5D-5L Profiles and Values in Three Patient Groups Y Feng, N Devlin, A Bateman, B Zamora, D Parkin Value in Health 22 (3), 355-361, 2019 | 11 | 2019 |
| What Determines the Health Care Expenditure of High Income Countries? A Dynamic Estimation Y Feng, T Watt, A Charlesworth, G Marsden, A Roberts, J Sussex Applied Economics and Finance 4 (6), 1-16, 2017 | 8 | 2017 |
| Details matter: Physician responses to multiple payments for the same activity Y Feng, H Gravelle Social Science & Medicine, 2019 | 5 | 2019 |
| Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets B Mulhern, Y Feng, K Shah, MF Janssen, M Herdman, B van Hout, ... PharmacoEconomics 36 (6), 727-727, 2018 | 4 | 2018 |
| An exploration of the non‐iterative time trade‐off method to value health states Y Feng, AR Hole, M Karimi, A Tsuchiya, B van Hout Health economics 27 (8), 1247-1263, 2018 | 3 | 2018 |
| A developed theoretical model of paid and unpaid work in healthcare supply Y Feng Economics Bulletin 32 (4), 3082-3089, 2012 | | 2012 |
